About Carla Grandori
Form D filings for SEngine Precision Medicine from 2018 to 2023 list Carla Grandori as president and CEO, director.
Carla Grandori first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Carla Grandori in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Carla Grandori works with at each company, as listed on that company's latest Form D.
SEngine Precision Medicine, Inc. · Form D, Mar 10, 2023
CK
Christopher Kemp
Executive officer and promoter
PP
Pablo Prichard
Director
TH
Tony Hsu
Executive officer
EB
Elliott Burkland
Director